Volume | 1,087,603 |
|
|||||
News | - | ||||||
Day High | 0.097 | Low High |
|||||
Day Low | 0.088 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Navidea Biopharmaceuticals Inc | NAVB | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.097 | 0.088 | 0.097 | 0.0931 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
865 | 1,087,603 | $ 0.0905193 | $ 98,449 | - | 0.0626 - 0.35 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:08:23 | 10 | $ 0.089051 | USD |
Navidea Biopharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
8.89M | 99.83M | - | 66k | -17.22M | -0.17 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Navidea Biopharmaceuticals News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NAVB Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0923 | 0.0988 | 0.088 | 0.0945655 | 2,528,864 | -0.0033 | -3.58% |
1 Month | 0.079 | 0.145 | 0.0765 | 0.1048613 | 6,628,161 | 0.01 | 12.66% |
3 Months | 0.1024 | 0.145 | 0.0626 | 0.0993304 | 4,861,102 | -0.0134 | -13.09% |
6 Months | 0.2846 | 0.32955 | 0.0626 | 0.1008765 | 5,291,982 | -0.1956 | -68.73% |
1 Year | 0.2292 | 0.35 | 0.0626 | 0.1043483 | 2,679,440 | -0.1402 | -61.17% |
3 Years | 2.86 | 3.15 | 0.0626 | 0.2961079 | 1,010,082 | -2.77 | -96.89% |
5 Years | 0.23 | 5.3569 | 0.0626 | 0.6313757 | 837,544 | -0.141 | -61.3% |
Navidea Biopharmaceuticals Description
Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes. |